Pathology of lung cancer
- PMID: 22054879
- DOI: 10.1016/j.ccm.2011.08.005
Pathology of lung cancer
Abstract
This article reviews current concepts in pathologic classification of lung cancer based on the 2004 World Health Organization classification of lung tumors and the 2011 International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification of lung adenocarcinoma. Preinvasive lesions are discussed. The major changes in lung disease diagnosis affected by the IASLC/ATS/ERS classification are presented. For adenocarcinomas diagnosed in small biopsies, specific terminology and diagnostic criteria are proposed along with recommendations for strategic management of tissue and EGFR mutation testing in patients with advanced adenocarcinoma. Histologic criteria are also presented for other tumors.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.J Thorac Cardiovasc Surg. 2014 Jan;147(1):54-9. doi: 10.1016/j.jtcvs.2013.08.058. Epub 2013 Oct 13. J Thorac Cardiovasc Surg. 2014. PMID: 24131786
-
Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing.Semin Respir Crit Care Med. 2011 Feb;32(1):22-31. doi: 10.1055/s-0031-1272866. Epub 2011 Apr 15. Semin Respir Crit Care Med. 2011. PMID: 21500121 Review.
-
The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.J Thorac Dis. 2014 Oct;6(Suppl 5):S526-36. doi: 10.3978/j.issn.2072-1439.2014.01.27. J Thorac Dis. 2014. PMID: 25349703 Free PMC article. Review.
-
Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.Arch Pathol Lab Med. 2014 Oct;138(10):1353-7. doi: 10.5858/arpa.2013-0376-OA. Epub 2014 Feb 26. Arch Pathol Lab Med. 2014. PMID: 24571650
-
Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.Clin Lung Cancer. 2016 Sep;17(5):e57-e64. doi: 10.1016/j.cllc.2016.03.009. Epub 2016 Mar 30. Clin Lung Cancer. 2016. PMID: 27137345 Review.
Cited by
-
High mitochondrial DNA levels accelerate lung adenocarcinoma progression.Sci Adv. 2024 Nov;10(44):eadp3481. doi: 10.1126/sciadv.adp3481. Epub 2024 Nov 1. Sci Adv. 2024. PMID: 39485842 Free PMC article.
-
The Clinical Significance of Deglycosylated PD-L1 Level Detection Using 28-8 Monoclonal Antibody in Lung Adenocarcinoma.Int J Gen Med. 2022 Sep 19;15:7383-7393. doi: 10.2147/IJGM.S381530. eCollection 2022. Int J Gen Med. 2022. PMID: 36164284 Free PMC article.
-
Systematic profiling of invasion-related gene signature predicts prognostic features of lung adenocarcinoma.J Cell Mol Med. 2021 May 31;25(13):6388-402. doi: 10.1111/jcmm.16619. Online ahead of print. J Cell Mol Med. 2021. PMID: 34060213 Free PMC article.
-
Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.Oncotarget. 2016 Nov 1;7(44):72084-72098. doi: 10.18632/oncotarget.12290. Oncotarget. 2016. PMID: 27765924 Free PMC article.
-
Factors associated with disease-specific survival of patients with non-small cell lung cancer.J Bras Pneumol. 2016 Sep-Oct;42(5):317-325. doi: 10.1590/S1806-37562015000000069. J Bras Pneumol. 2016. PMID: 27812630 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous